How To Overcome Data Challenges And Experience The Benefits Of DCTs - Guidance For Patients, Sites, And Sponsors
In-home patient data collection holds the promise of reducing site visits and easing the workload of on-site staff and monitors, all while providing more timely insights. However, it often comes with the challenge of complex programming and integration, which has hindered its widespread adoption.
Although, with recent advancements in technology, the industry has developed and continues to create better ways to collect patient data at home. Join Walker Bradham, Product Management Lead for Zelta, Merative’s clinical trials solutions business, and Ullas Arabhavi, Head of Product Management at George Clinical, as they explore how a data-driven strategy and innovative, user-friendly integration tools are forging stronger connections with patients, ensuring consistent data flows, and accelerating the generation of insights.
During this session, presenters reveal how to revolutionize approaches to customizing data management tasks when collecting and curating data for a DCT clinical trial. Other key takeaways include:
- Insight into the hurdles of data integration and extraction.
- An overview of how George Clinical effectively employed Zelta to capture data from remote patients in a phase III cardiovascular clinical trial.
- How George Clinical streamlined the transfer of blood pressure data from thousands of subjects through Zelta, eliminating numerous site visits for these subjects.
- Advantages of integrating remote sensors, like blood pressure measuring devices, with the EDC system to facilitate real-time data collection from thousands of participants in their homes.
- A dissection of how the “one size fits all” concept may not be applicable when implementing DCT concepts.
Access the webinar below to watch the entire presentation and learn to navigate data hurdles for a rewarding DCT experience.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.